RESUMEN
BACKGROUND: Up-regulation of the hepatocyte growth factor (HGF), its transmembrane tyrosine kinase receptor (c-Met), and urokinase type plasminogen activator (uPA), is associated with the development and metastasis of various types of cancers. However, the mechanisms by which HGF/c-Met signaling mediates cancer progression and metastasis are unclear. METHODS: We investigated the roles of HGF/c-Met in tumor progression and metastasis in NUGC-3 and MKN-28 stomach cancer cell lines. RESULTS: Treatment with HGF increased c-Met phosphorylation in a dose-dependent manner, as well as increasing cell proliferation. HGF treatment also increased the protein level and the activity of uPA in NUGC-3 and MKN-28 cells. A monoclonal antibody against human uPA receptor (uPAR), mAb 3936, inhibited HGF-mediated tumor cell invasion in a dose-dependent manner. Down-regulation of uPA using uPA-shRNA induced a decrease in in vitro cell invasion in NUGC-3 cells. CONCLUSIONS: These results suggest that NUGC-3 and MKN-28 cells express functional c-Met, which may provide a therapeutic target for interfering with metastases of cancer cells by inhibiting uPA and uPAR-mediated proteolysis.
Asunto(s)
Humanos , Activador de Plasminógeno de Tipo Uroquinasa/antagonistas & inhibidores , Neoplasias Gástricas/tratamiento farmacológico , Transducción de Señal/efectos de los fármacos , Receptores de Factores de Crecimiento/efectos de los fármacos , Proteínas Tirosina Quinasas Receptoras/efectos de los fármacos , Proteínas Proto-Oncogénicas c-met/efectos de los fármacos , Metástasis de la Neoplasia , Factor de Crecimiento de Hepatocito/metabolismo , Progresión de la Enfermedad , Adenocarcinoma/tratamiento farmacológicoRESUMEN
Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) was performed on a series of indole/benzoimidazole-5-carboxamidines as urokinase plasminogen activator (uPA) inhibitors. The ligand molecular superimposition on template structure was performed by atom/shape-based RMS fit, multifit, and RMSD fit methods.The removal of two outliers from the initial training set of 30 molecules improved the predictivity of the models. The statistically significant model was established from 28 molecules, which were validated by evaluation of test set of nine compounds. The atom based RMS alignment yielded best predictive CoMFA model (r2cv ¬ 0:611, r2cnv ¬ 0:778, F value¬43.825, r2bs ¬ 0:842, r2pred ¬ 0:616with two components) while the CoMSIA model yielded (r2cv ¬ 0:499, r2cnv ¬ 0:976, F value¬96.36, r2bs ¬ 0:993, r2pred ¬ 0:694 with eight components). The contour maps obtained from 3D-QSAR studies were appraised for the activity trends of the molecules analyzed. The results indicate that the steric, electrostatic, and hydrogen bond donor/acceptor substituents play significant role inuPA activity and selectivity of these compounds. The data generated from the present study can be used as putative pharmacophore in the design of novel, potent, and selective urokinase plasminogen activator inhibitors as cancer therapeutics.